Indaptus Therapeutics is trading at $1.69 (-7.14%) in after-hours trading after closing the regular session at $1.82, with the move appearing to be driven by market conditions rather than company-specific news.
- The decline lacks a clear catalyst, such as an earnings release or corporate announcement, suggesting the move is tied to thin after-hours liquidity.
- Broader market weakness and lower-pointing futures have created a risk-off environment, impacting volatile small-cap stocks.
- Significant price swings over the past week have contributed to increased sensitivity during extended-hours trading sessions.